Skip to main content
. 2021 Mar 29;23(7):1281–1287. doi: 10.1038/s41436-021-01134-9

Table 1.

Demographics of patients with HCM and single MYBPC3 VUS.

STRUM (+) n = 39 (37%) STRUM (−) n = 66 (63%) p value STRUM (+) vs. STRUM (−)
Baseline characteristics
 Female, n (%) 10 (26%) 14 (21%) 0.6308
 Age at diagnosis, mean (STD), year 40.31 (17.13) 41.34 (21.17) 0.9930
 Follow-up time, mean (STD), year 9.82 (10.00) 12.18 (11.83) 0.7575
 Maximum BMI, mean (STD) kg/m2 28.87 (4.10) 27.96 (6.03) 0.9390
 lb/ft2 685.09 (97.29) 663.49 (143.09)
Race, n % 0.5107
  White 35 (90%) 60 (91%)
  Black 2 (5%) 1 (2%)
  Other/not reported 2 (5%) 5 (8%)
 Proband, n (%) 35 (90%) 64 (97%) 0.1232
 Family history HCM, n (%) 13 (33%) 19 (29%) 0.6249
 Family history SCD n (%) 8 (21%) 9 (14%) 0.3553
Echocardiogram data
 Maximal LVWT, mean (STD), mm 22.73 (6.97) 20.83 (7.29) 0.4287
 Minimum LVEF, mean (STD), % 59.88 (8.32) 60.12 (11.34) 0.9996
 LVOT peak gradient ≥30 mmHg; n (%) 9 (23%) 21 (32%) 0.3380

BMI body mass index, HCM hypertrophic cardiomyopathy, LVEF left ventricular ejection fraction, LVWT left ventricular wall thickness, LVOT left ventricular outflow tract, SCD sudden cardiac death, VUS variant of uncertain significance.